Trials / Unknown
UnknownNCT03427944
the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD
the Effect of Calcium Dobesilate on Non Dialysis Patients With Chronic Renal Failure
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the feasibility of calcium dobesilate in the treatment of microvascular injury provides new ideas and theoretical basis for the prevention and treatment of chronic renal failure.
Detailed description
The deterioration of renal function is closely related to microvascular damage, calcium dobesilate is known as microcirculation protective agent, the investigators will further study its effect of non dialysis patients with chronic renal failure and explore the feasibility of calcium dobesilate in treatment of renal microvascular injury, the investigators will provide new ideas and theoretical basis for the prevention and treatment of chronic renal failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium Dobesilate group | Calcium dobesilate was used to treat patients with chronic renal failure on the basis of conventional treatment. |
| DRUG | Conventional Treatment group | Conventional treatment were used to treat patients with chronic renal failure. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2018-02-09
- Last updated
- 2018-02-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03427944. Inclusion in this directory is not an endorsement.